R&D without translation is just cost. Success isn’t just about science or technology—it’s about aligning invention with business goals and market pull. Each year, universities and labs generate extraordinary IP that stalls in disclosure portals and patent dockets—not for lack of brilliance, but for lack of translation. Specs don’t equal strategy; claims don’t equal customers. Corporates can’t see fit, timing, or unit economics; TTOs can’t package multi-asset stories that map to real roadmaps. The result: stranded patents, slow deals, diluted licenses, and missed category leadership. We exist to bridge that gap—bundling, narrating, and operationalizing IP as deployable systems with a measurable path to market.